🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
This clinical trial studies fludarabine phosphate and total-body radiation ...
Status
Completed
Location
University of Arizona Health Sciences Center
Start Date
2000-12
Trial ID
NCT00014235
This study is being done to test a transplant method that may have fewer si...
Status
Suspended
Location
St. Jude Children's Research Hospital
Start Date
2020-04-30
Trial ID
NCT04362293
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
This is a continuation of a pilot study which is now regarded as a phase II...
Status
Completed
Location
University of Nebraska Medical Center, Section of Oncology/Hematology
Start Date
2000-12-08
Trial ID
NCT00571662
Treatments Being Tested
The goal of this clinical trial is to compare SBRT (Stereotactic Body Radio...
Status
Recruiting
Location
Centre Intégré de Cancérologie, CHU de Québec-Université Laval
Start Date
2019-09-30
Trial ID
NCT06052683
RATIONALE: Drugs used in chemotherapy such as fludarabine use different way...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2000-01
Trial ID
NCT00006233
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2000-10
Trial ID
NCT00008151
This is a Phase II trial to determine the efficacy and safety of stereotact...
Status
Completed
Location
Houston Methodist Cancer Center
Start Date
2017-07-01
Trial ID
NCT03004183
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells...
Status
Completed
Location
Rocky Mountain Cancer Centers - Denver Midtown
Start Date
1999-11
Trial ID
NCT00044954